PURPOSE Depression is associated with lowered work functioning, including absences, impaired productivity, and decreased job retention. Few studies have examined depression symptoms across a continuum of severity in relationship to the magnitude of work impairment in a large and heterogeneous patient population, however. We assessed the relationship between depression symptom severity and productivity loss among patients initiating treatment for depression. METHODS Data were obtained from patients participating in the DIAMOND (Depression Improvement Across Minnesota: Offering a New Direction) initiative, a statewide quality improvement collaborative to provide enhanced depression care. Patients newly started on antidepressants were surveyed with the Patient Health Questionnaire 9-item screen (PHQ-9), a measure of depression symptom severity; the Work Productivity and Activity Impairment (WPAI) questionnaire, a measure of loss in productivity; and items on health status and demographics.
INTRODUCTION

D
epression is prevalent and incurs substantial indirect costs associated with reduced work functioning, including absences, impaired productivity, and even decreased job retention across a wide variety of occupations. [1] [2] [3] [4] In addition, several studies have shown that even minor or subthreshold depression (including dysthymia) is related to poorer work performance. 5, 6 Fewer studies have examined depression symptoms across a continuum of severity in relationship to the magnitude of work loss that includes both absences and impaired productivity. Simon et al 7 found that among outpatients treated for bipolar disorder, depression severity was strongly and consistently associated with a decreased probability of employment and more days of absence due to illness. Backenstrass et al 8 characterized a spectrum of depressive symptoms across 3 increasing levels of severity (nonspecifi c, minor, and major) and found an increasing number of days of absence due to illness with each additional level of Arne Beck, PhD 1, 2 A. Lauren Crain, PhD 3 Leif I. Solberg, MD 3 Jürgen Unützer, MD, MPH 4 Russell E. Glasgow, PhD 5 Michael V. Maciosek, PhD 3 Robin Whitebird, PhD, MSW 3 symptom severity. Both of these studies had selected samples, however-patients with a bipolar disorder diagnosis and patients from 6 family practices in a small town near Heidelberg, Germany, respectivelylimiting their generalizability.
The goal of this study was to investigate further the relationship between a continuum of depression symptom severity and the magnitude of productivity loss in a large, heterogeneous, and representative sample of outpatients initiating treatment for depression.
METHODS
Setting
We analyzed baseline data collected for a study of a statewide depression quality improvement initiative in Minnesota, called Depression Improvement Across Minnesota: Offering a New Direction (DIAMOND). All groups and clinics that intended to participate by implementing the initiative in their primary care clinics were invited to be in the DIAMOND study. A total of 88 clinics from 23 medical groups participated. Details on the study design and methods are presented elsewhere. 
Patient Recruitment and Enrollment
All patients with health plan claims data showing them to be newly started on antidepressant medications at a participating clinic were identifi ed on a weekly basis by the health plans and sent a letter about the study, providing them a 1-week opportunity to opt out before being called by the research survey center to determine eligibility for participation and to complete a baseline questionnaire by phone. Patients were eligible if they were older than 18 years of age, had fi lled a new antidepressant prescription (and none in the prior 4 months) from a primary care clinician at a participating clinic for the treatment of depression, and had a depression symptom severity score of 7 or higher on the Patient Health Questionnaire 9-item screen (PHQ-9). Although part-or full-time employment was not an eligibility criterion for participation in the larger DIA-MOND study, because we focused on the relationship between productivity loss at work and depression, we included in our analysis only the subset of patients employed for wages at least part time. Patients completing this baseline questionnaire were also asked for permission to resurvey them 6 months later.
The study protocol was reviewed, approved, and monitored by the HealthPartners Institutional Review Board.
Measures
We used patient self-report questionnaires to obtain information on depression severity, work absence and productivity impairment, health status (a single item asking patients to rate their overall health), and demographic characteristics. The PHQ-9 was used to measure the severity of depression symptoms. It is widely accepted as a valid measure of depression severity. [10] [11] [12] [13] Questions about work function were obtained from the Work Productivity and Activity Impairment (WPAI) questionnaire, [14] [15] [16] a self-report measure of the amount of absence from work due to health problems, as well as productivity impairment while at work ("presenteeism") experienced during the previous 7 days. We computed additional measures to estimate the percent of work time missed due to health, percent impairment while working due to health, and percent of overall productivity loss due to health. 16 Percent work time missed due to health, a measure of absenteeism, was calculated as the hours missed during the previous 7 days divided by the hours missed plus the hours worked during this period. Percent impairment while working due to health, a measure of presenteeism, was calculated as a 10-point rating of degree of impairment while at work divided by 10. The number of hours of productivity impairment at work was calculated as the hours actually worked multiplied by the percent impairment while at work. The proportion of expected work time that was missed or affected because of health problems over the previous 7 days (productivity loss) was calculated as the percent of work time missed plus the percent of time at work multiplied by impairment while there.
Statistical Analyses
To investigate the relationship between depression symptoms and productivity loss while adjusting for potential confounders, we estimated general linear models, using the PROC GLM program of SAS, version 9.1.3 (SAS Institute Inc, Cary, North Carolina). This analytic approach was chosen after determining that there were no signifi cant clustering effects and, therefore, the GLM is equivalent to a mixed model. Because the relationships between depression and both work loss and productivity were similar, we used the combined variable, productivity loss, in our subsequent multivariate modeling. The PHQ-9 scores and productivity loss were both treated as continuous variables in the model. We included as covariates multiple demographic variables-age, sex, race/ethnicity (non-Hispanic white vs Hispanic or nonwhite), education (high school or less vs some college or more), employment status (full vs part time), and marital status (coupled vs single)-and self-reported health status, categorized as a combination of excellent, very good, and good vs a combination of fair and poor. We tested for interaction terms between PHQ-9 and covariates and did not fi nd any to be signifi cant, so we eliminated the interaction terms from the model.
RESULTS
Patient Enrollment and Demographic Characteristics
During a 25-month period, 11,889 patient names were submitted to the research survey center; however, 40% of these patients could not be contacted, and of those who agreed to be screened, 75% did not meet eligibility criteria for the study. The study enrollment data are shown in Table 1 , indicating that to date, 1,168 patients have been contacted, assessed for eligibility, consented, and enrolled. We analyzed data on the relationship between depression and work impairment for the subsample of 771 patients (66%) who reported that they were working for wages either full or part time at the time of their interview. Demographic characteristics of these patients are shown in Table 2 .
Depression Symptoms
We divided PHQ-9 scores into 4 ordinal categories corresponding to increasing levels of depression severity. A score of 7 to 9 indicates mild or minor symptoms of depression, a score of 10 to 14 is in the moderate depression range, 15 to 19 is consistent with major depression and considered a diagnostic threshold, and 20 or higher is considered severe depression. The plurality of patients (292 or 38%) had scores in the moderate range of depression symptoms, followed by scores in the minor range (263 or 34%), major range (159 or 21%), and severe range (57 or 7%). The mean PHQ-9 score was 12.2 (SD = 4.3). Table 3 presents descriptive data on the WPAI items. Patients reported that over the previous 7 days, an average of 3.1 hours, or 8.0%, of their total usual working hours were missed because of health conditions. The average rating of the degree of impairment while at work was 3.5 on Relationship Between PHQ-9 and WPAI Figure 1 graphically shows the relationship between each category of depression symptom severity, as assessed with the PHQ-9, and productivity loss. It illustrates the strong linear relationship between depression symptom severity and the combination of work loss and productivity impairment. It also shows that even minor symptoms were associated with a considerable loss of productivity. The overall multivariate model for productivity loss containing all covariates was signifi cant, and the included variables explained 10.5% of the variability among patients in this outcome (F = 10.26, P <.001, model R 2 = .105). Table 4 displays the individual variables in the model. There was a positive and signifi cant association between PHQ-9 scores and productivity loss, with each 1-point increase in score associated with an additional 1.65% loss of productivity (P <.001). In addition, full-time vs parttime employment status and fair or poor health vs excellent, very good, or good health were also associated with greater productivity loss (P <.001 and P = .045, respectively).
Work Loss and Productivity
Because our sample of 771 employed individuals represented only 66% of those with complete baseline data for this analysis, we conducted a subanalysis to determine whether employment status was related to depression severity among all working-age participants, defi ned as those aged 18 to 64 years. Results indicated that mean PHQ-9 scores were higher among the 325 study participants reporting no employment (mean = 13.30, SD = 4.90) than among the 757 study participants reporting full-or part-time employment (mean = 12.17, SD = 4.31) (t = 3.62, df = 549.2, P <.001).
DISCUSSION
Baseline data from this large sample of patients demonstrate a linear, monotonic relationship between depression symptom severity and productivity loss; Notes: The model had an estimated intercept of 36.50 and an error of 1.74. Positive estimates indicate loss of productivity; negative estimates indicate gain of productivity. Productivity loss is defi ned as the combination of absenteeism (percent of time missed in the past 7 days due to health) and presenteeism (percent impairment at work in the past 7 days due to health). These measures were obtained from the Work Productivity and Activity Impairment (WPAI) questionnaire.
a The general linear model shows the relationship between PHQ-9 score and productivity loss adjusted for all other variables listed in the table. b Combination of Hispanic ethnicity and non-white race categories listed in Table 2. c Divorced, separated, widowed, or never married. 
PHQ-9 score at enrollment
Percent that is, the more severe depression symptoms were, the greater the amount of productivity lost. Specifi cally, we found that for every 1-point increase in patients' PHQ-9 scores, they experienced an additional mean productivity loss of 1.65%. This relationship was observed after adjusting for, and was not modifi ed by, demographics and self-reported health status. The fi nding of greater productivity loss for those employed full time vs part time may be explained by the fact that full-time employees have less fl exibility in their schedules, requiring the use of sick absence days and working while negatively affected by depression symptoms. Greater productivity loss among those reporting fair or poor health is consistent with literature on the impact of health conditions on work function.
Although the relationship between depression symptoms and both work loss and presenteeism appeared similar, the relative impact of each differed. The percent of work loss reported over the last 7 days ranged from 4% (PHQ-9 scores of 7-9) to 17% (PHQ-9 scores of ≥20), whereas the percent of productivity impairment over the same period ranged from 28% (PHQ-9 scores of 7-9) to 47% (PHQ-9 scores of ≥20). The greater productivity impairment reported likely refl ects the limits on sick days available for employees. It also suggests that in relative terms, presenteeism due to depression may represent a more noteworthy problem than absenteeism for employers.
The magnitude of productivity loss in this sample of patients (38%) is large compared with normative data for the WPAI that include individuals without health conditions (8%), as well as those with such conditions as diabetes (15%), asthma (15%), back pain (16%), obesity (18%), angina (20%), and chronic pain (22%) (personal communication, Steve Schwartz, Director of Research, Health Media, Inc, Ann Arbor, Michigan; August 25, 2010). The greater productivity loss reported by our patients may be due in part to the fact that the study sample was recruited from outpatient clinics during treatment initiation, when depression symptoms were presumably at a peak and recent work function was most affected. In fact, productivity loss for various health conditions is greater when reported in observational studies or clinical trials involving these patients as compared with populationbased surveys. 17, 18 For example, recent studies using the WPAI with clinic-based patient samples show a 28% productivity loss associated with severe asthma, 38% for Crohn disease, and 20% for allergic rhinitis. 19 Moreover, similar to our fi ndings for depression, the majority of these studies show the loss increases with the severity of the condition.
The fi nding of greater depression severity among the 34% of participants not employed raises the question of whether and how depression severity may contribute to unemployment. Symptoms of depression (lack of initiative, poor self-esteem, etc) are a major barrier to getting a job, holding a job, or both. The relationship of depression severity and productivity loss we report for only the employed sample may therefore well underestimate the impact of depression on work function and employment status in general.
This study adds to the growing body of literature suggesting the importance of treating depression in order to restore psychosocial function in addition to remit symptoms. 5 These studies have suggested that even minor depression symptom severity is associated with work impairment, and although work performance improves in proportion to depression symptom remission after treatment, 20, 21 it remains consistently lower among individuals showing clinical improvement in depression compared with nondepressed control individuals. 22 Fortunately, high-quality depression treatment has been found to reduce symptoms, to improve work function, and to be cost-effective. 23 Nonpharmacologic treatments may be of benefi t for even minor depression, as demonstrated by the randomized trial of Wang et al 24 testing telephonic care management of workers with depression (the benefi t from pharmacologic treatment of minor depression is less evident 25 ). Considering the strength of the relationship between depression symptoms and work performance, our fi ndings also underscore the potential utility of using the PHQ-9 to provide health professionals with insights not only about depression severity, but also about work function. Primary care clinicians who better appreciate the impairment in work function associated with the continuum of minor to severe symptoms of depression may have an extra incentive to treat patients more intensively and to full remission whenever possible, rather than accepting minor degrees of improvement. Treating to full remission may be particularly important given the problem of clinical inertia that depression treatment often poses, that is, lack of follow-up of and treatment adjustments for patients initiated on antidepressants. Moreover, results from this study indicate that different levels of depression symptom severity can be directly translated into magnitude of work impairment. Using a relatively easy to administer instrument such as the PHQ-9 can serve both to help primary care clinicians assess depression in their patients, and once it is identifi ed, to understand at a more precise level how much work impairment may be associated with different levels of depression symptom severity. Given the importance of work in peoples' lives, clinicians might wish to ask patients with high PHQ-9 scores about how their depression is affecting their work function, how their work might be affecting their depression, and how treatment for depression or other interventions might help patients not only feel better, but also function better at work and for that matter, in their lives overall. Focusing the discussion on the functional impact of depression may provide depressed patients who are hesitant to acknowledge or treat their depression additional motivation to engage in treatment.
Taking the perspective of employers, these results provide more tangible evidence of the potential labor costs of even minor depression symptoms and the potential to realize a return on investment from ensuring that their employees who experience a broader range of depression symptom severity than might typically be considered to warrant treatment receive the most effective treatments possible. 24, 26, 27 Our study has both strengths and limitations. Our large real-world sample was obtained from members of a majority of health plans (including Medicaid plans) across the state of Minnesota within the context of a natural experiment, using minimal inclusion and exclusion criteria. The patients thus constitute a broadly representative sample of depressed primary care patients from a variety of backgrounds, income levels, and occupational categories. The results, therefore, should be widely generalizable (except regarding race and/or ethnicity, which have limited diversity in this geographic region). In addition, our ability to examine the relationship between the actual level of self-reported depressive symptomatology and the amount of work loss and productivity impairment is more informative than that in many studies that have examined work loss and productivity impairment only among patients who received a diagnosis of depression or who reached a threshold of symptom severity classifying them as having major depression. Our fi ndings do suggest that even subclinical levels of depression are associated with work absence and productivity impairments.
One limitation of this study is the lack of detailed data on other health conditions that might be associated with work loss and productivity impairment. The inclusion of self-reported health status provides a less precise measure of disease burden than actual data about medical comorbidities. Unfortunately, we did not have access to comorbidity data across all health plans participating in the study. Regarding the impact of other psychiatric comorbidities on productivity loss, future studies might benefi t from using the recently published My Mood Monitor (M-3) instrument to assess a greater number of mental disorders than is possible with the PHQ-9. 28 An additional limitation is that our analyses were restricted to patients reporting at least some employment, excluding those not in the labor force (eg, retirees), because our focus was on work function. Moreover, this study does not provide data on individuals with PHQ-9 scores of less than 7 (ie, nondepressed individuals). As mentioned earlier, however, normative data on productivity loss for nondepressed individuals with no other chronic medical conditions is 8%, which is considerably lower than our fi ndings of 29.6% for those with minor depression (PHQ-9 scores of 7-9).
Analysis of the relationship between levels of depression symptoms and broad self-reported measures of general functional status across the larger sample of study patients is beyond the scope of this article, but will be reported in a subsequent article. Finally, because insuffi cient numbers of study patients have reached the follow-up assessment time frame, data are not available to examine the relationship between potential improvements in depression symptoms and work performance, and whether this relationship differs depending on the level of initial depression symptom severity reported. We look forward to reporting these results when such data become available.
In conclusion, this study shows a relationship between levels of depression symptoms and productivity loss, suggesting that even minor levels of depression are associated with decrements in work function. The signifi cant relationship between depression symptoms, as measured by the widely used PHQ-9, and impairments in work function raises the possibility of using this questionnaire as a tool to assess both depression symptoms and work function in patients. Taking the perspective of employers, promoting evidence-based depression management programs to employees experiencing even minor depression may have the potential to reduce work loss and productivity impairment, thus yielding a return on investment in such programs.
Ultimately, the goal of this work is to understand how effective depression care can improve both depression symptoms and work function. Once suffi cient numbers of patients have complete 6-month follow-up data, we also will be able to explore the relationship between depression symptom remission and improvement in work function.
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